Pharmacotherapy for lower respiratory tract infections

Bibliography

• Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2013;380:2095-128
   Web of Science ®Google Scholar
• Llor C. Acute bronchitis: aetiology and treatment. Eur Respir Monogr 2013;60:1-17
   Google Scholar
• Wenzel RP, Fowler AA III. Acute bronchitis. N Engl J Med 2006;355:2125-30
   Google Scholar
• Louie JK, Hacker JK, Gonzales R, et al. Characterization of viral agents causing acute respiratory infection in a San Francisco University Medical Center Clinic during the influenza season. Clin Infect Dis 2005;41:822-8
   PubMed Web of Science ®Google Scholar
• Wilkinson TM, Hurst JR, Perera WR, et al. Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD. Chest 2006;129:317-24
   PubMed Web of Science ®Google Scholar
• Gonzales R, Sande MA. Uncomplicated acute bronchitis. Ann Intern Med 2000;133:981-91
   PubMed Web of Science ®Google Scholar
• Ward JI, Cherry JD, Chang S-J, et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med 2005;353:1555-63
   PubMed Web of Science ®Google Scholar
• Rohani P, Drake JM. Pertussis in the US. Epidemics 2011;3(3-4):183-8
   PubMed Web of Science ®Google Scholar
• Braman SS. Chronic cough due to acute bronchitis: ACCP evidence-based clinical practice guidelines. Chest 2006;129(Suppl):95S-103S
   Google Scholar
• Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections – full version. Clin Microbiol Infect 2011;17(Suppl 6):E1-59
   PubMed Web of Science ®Google Scholar
• Grover ML, Mookadam M, Rutkowski RH, et al. Acute respiratory tract infection: a practice examines its antibiotic prescribing habits. Fam Pract 2012;61(6):330-5
   Google Scholar
• Butler CC, Kelly MJ, Hood K, et al. Antibiotic prescribing for discoloured sputum in acute cough/lower respiratory tract infection. Eur Respir J 2011;38(1):119-25
   Google Scholar
• Little P, Stuart B, Moore M, et al. Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomized, placebo-controlled trial. Lancet Infect Dis 2013;13:123-9
   PubMed Web of Science ®Google Scholar
• Altunaiji SM, Kukuruzovic RH, Curtis NC, et al. Antibiotics for whooping cough. Cochrane Database Syst Rev 2011;7:CD004404
   Google Scholar
• Peces-Barba G, Barberà JA, Agustí A, et al. Diagnosis and management of chronic obstructive pulmonary disease: joint guidelines of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) and the Latin American Thoracic Society (ALAT)]. Arch Bronconeumol 2008;44(5):271-81
   Google Scholar
• Miravitlles M, Anzueto A. Antibiotics for acute and chronic respiratory infection in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013;188(9):1052-7
   Google Scholar
• Mohan A, Chandra S, Agarwal D, et al. Prevalence of viral infection detected by PCR and RT-PCR in patients with acute exacerbation of COPD: a systematic review. Respirology 2010;15:536-42
   PubMed Web of Science ®Google Scholar
• Mallia P, Message SD, Gielen V, et al. Experimental Rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation. Am J Respir Crit Care Med 2011;183:734-42
   PubMed Web of Science ®Google Scholar
• Rangelov K, Sethi S. Role of infections. Clin Chest Med 2014;35:87-100
   PubMed Web of Science ®Google Scholar
• Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 2008;359:2355-65
   PubMed Web of Science ®Google Scholar
• Rosell A, Monso E, Soler N, et al. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease. Arch Intern Med 2005;165:891-7
   PubMed Web of Science ®Google Scholar
• Papi A, Bellettato CM, Braccioni F, et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 2006;173:1114-21
   PubMed Web of Science ®Google Scholar
• Restrepo MI, Mortensen EM, Pugh JA, et al. COPD is associated with increased mortality in patients with community-acquired pneumonia. Eur Respir J 2006;28:346-51
   PubMed Web of Science ®Google Scholar
• Nouira S, Marghli S, Belghith M, et al. Once daily oral ofloxacin in chronic obstructive pulmonary disease exacerbation requiring mechanical ventilation: a randomized placebo-controlled trial. Lancet 2001;358:2020-5
   PubMed Web of Science ®Google Scholar
• Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987;106:196-204
   PubMed Web of Science ®Google Scholar
• Blasi F, Ewig S, Torres A, Huchon G. A review of guidelines for antibacterial use in acute exacerbations of chronic bronchitis. Pulm Pharmacol Ther 2006;19(5):361-9
   Google Scholar
• Quon BS, Gan WQ, Sin DD. Contemporary management of acute exacerbations of COPD: a systematic review and metaanalysis. Chest 2008;133(3):756-66
   PubMed Web of Science ®Google Scholar
• Rothberg MB, Pekow PS, Lahti M, et al. Antibiotic therapy and treatment failure in patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. JAMA 2010;303:2035-42
   PubMed Web of Science ®Google Scholar
• Wilson R, Anzueto A, Miravitlles M, et al. Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results. Eur Respir J 2012;40:17-27
   PubMed Web of Science ®Google Scholar
• Anzueto A, Miravitlles M. Short-course fluoroquinolone therapy in exacerbations of chronic bronchitis and COPD. Respir Med 2010;104:1396-403
   Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease. Global strategy for diagnosis, management and prevention of chronic obstruction pulmonary disease. 2010. Available from: www.goldcopd.org/
   Google Scholar
• Alberts RK, Connett J, Bailey WC, et al. Azithromycin for prevention of exacerbations of COPD. N Engl J Med 2011;365:689-98
   Google Scholar
• Pomares X, Montón C, Espasa M, et al. Long-term azithromycin therapy in patients with severe COPD and repeated exacerbations. Int J Chron Obstruct Pulmon Dis 2011;6:449-56
   PubMed Web of Science ®Google Scholar
• He Z-Y, Ou L-M, Zhang J-Q, et al. Effect of 6 months of erythromycin treatment on inflammatory cells in induced sputum and exacerbations in chronic obstructive pulmonary disease. Respiration 2010;80:445-52
   PubMed Web of Science ®Google Scholar
• Seemungal TA, Wilkinson TM, Hurst JR, et al. Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations. Am J Respir Crit Care Med 2008;178:1139-47
   PubMed Web of Science ®Google Scholar
• Sethi S, Jones PW, Theron MS, PULSE Study Group. Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. Respir Res 2010;11:10
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Soler-Cataluña JJ, Calle M, et al. Spanish COPD guidelines (GesEPOC). Pharmacological treatment of stable COPD. Arch Bronconeumol 2012;48:247-57
   PubMed Web of Science ®Google Scholar
• Serisier DJ. Risks of population antimicrobial resistance associated with chronic macrolide use for inflammatory airway diseases. Lancet Respir Med 2013;1:262-74
   PubMedGoogle Scholar
• Dal Negro R, Micheletto C, Tognella S, et al. Tobramycin nebulizer solution in severe COPD patients colonized with Pseudomonas aeruginosa: effects on bronchial inflammation. Adv Ther 2008;25:1019-30
   Google Scholar
• Ho PL, Chan KN, Ip MS, et al. The effect of Pseudomonas aeruginosa infection on clinical parameters in steady-state bronchiectasis. Chest 1998;114:1594-8
   PubMed Web of Science ®Google Scholar
• Pasteur MC, Bilton D, Hill AT; British Thoracic Society Bronchiectasis non-CF Guideline Group. British Thoracic Society guideline for non-CF bronchiectasis. Thorax 2010;65(Suppl 1):i1-58. Review
   PubMed Web of Science ®Google Scholar
• Vendrell M, de Gracia J, Olveira C, et al. Diagnosis and treatment of bronchiectasis. Recommendations of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR). Arch Bronconeumol 2008;44(11):629-40
   PubMed Web of Science ®Google Scholar
• Bilton D, Henig N, Morrissey B, et al. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis. Chest 2006;130:1503-10
   PubMed Web of Science ®Google Scholar
• Murray MP, Govan JR, Doherty CJ, et al. A randomized controlled trial of nebulised gentamycin in non cystic fibrosis bronchiectasis. Am J Respir Crit Care Med 2011;183:491-9
   PubMed Web of Science ®Google Scholar
• Barker AF, Couch L, Fiel SB, et al. Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis. Am J Respir Crit Care Med 2000;162:481-5
   PubMed Web of Science ®Google Scholar
• Wilson R, Welte T, Polverino E, et al. Ciprofloxacin DPI in non-cystic fibrosis bronchiectasis: a phase II randomized study. Eur Respir J 2013;41:1107-15
   PubMed Web of Science ®Google Scholar
• Mogayzel PJ Jr, Naureckas ET, Robinson KA, Pulmonary Clinical Practice Guidelines Committee. Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health. Am J Respir Crit Care Med 2013;187(7):680-9
   PubMed Web of Science ®Google Scholar
• Wong C, Jayaram L, Karalus N, et al. Azithromycin for prevention of exacerbations in noncystic fibrosis bronchiectasis (EMBRACE): a randomized, double-blind, placebo-controlled trial. Lancet 2012;380(9842):660-7
   PubMed Web of Science ®Google Scholar
• Altenburg J, de Graaff CS, Stienstra Y, et al. Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non–cystic fibrosis bronchiectasis: the BAT randomized controlled trial. JAMA 2013;309:1251-9
   PubMed Web of Science ®Google Scholar
• Serisier DJ, Martin ML, McGuckin MA, et al. Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial. JAMA 2013;309:1260-7
   PubMed Web of Science ®Google Scholar
• Sevin CM, Peebles RS Jr. Infections and asthma: new insights into old ideas. Clin Exp Allergy 2010;40:1142-54
   Google Scholar
• Dhariwal J, Edwards MR, Johnston SL. Anti-viral agents: potential utility in exacerbations of asthma. Curr Opin Pharmacol 2013;13:331-6
   Google Scholar
• Toews GB. Impact of bacterial infections on airway diseases. Eur Respir Rev 2005;14:62-8
   Google Scholar
• Klemets P, Lyytikäinen O, Ruutu P, et al. Risk of invasive pneumococcal infections among working age adults with asthma. Thorax 2010;65:698-702
   PubMed Web of Science ®Google Scholar
• Talbot TR, Hartert TV, Mitchel E, et al. Asthma as a risk factor for invasive pneumococcal disease. N Engl J Med 2005;352:2082-90
   PubMed Web of Science ®Google Scholar
• Kraft M, Cassell GH, Pak J, Martin RJ. Mycoplasma pneumonia and chlamydia pneumonia in asthma: effect of clarithromycin. Chest 2001;121:1782-8
   Web of Science ®Google Scholar
• Johnston SL, Martin RJ. Chlamydophila pneumoniae and Mycoplasma pneumoniae: a role in asthma pathogenesis? Am J Respir Crit Care Med 2005;172:1078-89
   PubMed Web of Science ®Google Scholar
• Blasi F, Johnston SL. The role of antibiotics in asthma. Int J Antimicrob Agents 2009;29:485-93
   Web of Science ®Google Scholar
• Gielen V, Johnston SL, Edwards MR. Azithromycin induces antiviral responses in bronchial epithelial cells. Eur Respir J 2010;36:646-54
   PubMed Web of Science ®Google Scholar
• Johnston SL, Blasi F, Black PN, et al. The effect of telithromycin in acute exacerbations of asthma. N Engl J Med 2006;354:1589-600
   PubMed Web of Science ®Google Scholar
• Brusselle GG, VanderStichele C, Jordens P, et al. Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomized double-blind placebo-controlled trial. Thorax 2013;68:322-9
   PubMed Web of Science ®Google Scholar
• Simpson JL, Powell H, Boyle MJ, et al. Clarithromycin targets neutrophilic airway inflammation in refractory asthma. Am J Respir Crit Care Med 2008;177:148-55
   PubMed Web of Science ®Google Scholar
• Richeldi L, Ferrara G, Fabbri LM, et al. Macrolides for chronic asthma. Cochrane Database Syst Rev 2005(4):CD002997
   Google Scholar
• McDonough EA, Barrozo CP, Russell KL, Metzgar D. A multiplex PCR for detection of mycoplasma pneumoniae, chlamydophila pneumoniae, legionella pneumophila, and bordetella pertussis in clinical specimens. Mol Cell Probes 2005;19:314-22
   PubMedGoogle Scholar